EX3D: Exophthalmometry With 3D Face Scanners

Sponsor
University of Zurich (Other)
Overall Status
Recruiting
CT.gov ID
NCT04704414
Collaborator
(none)
180
1
1
40.6
4.4

Study Details

Study Description

Brief Summary

This study investigates diagnostic methods to measure eyeball protrusion with a smartphone face scanner compared to the traditional Hertel exophthalmometer. The study aims to validate a new reliable, fast and convenient smartphone app to measure the protrusion of the eyeball in different diseases such as Graves' disease, orbital tumors, orbital fractures or orbital inflammation, as well as other rare diseases.

Condition or Disease Intervention/Treatment Phase
  • Device: Exophthalmos measurement
N/A

Detailed Description

BACKGROUND: Accurate and reproducible measures of abnormal eyeball protrusion are important for diagnosing different causes of exophthalmos, as well as following patients with Grave's orbitopathy and retroorbital tumors. The current clinical gold standards for measuring abnormal eyeball protrusion is the Hertel exophthalmometer, which is prone to reading errors and inconvenient to use.

OBJECTIVE: The purpose of the EX3D-project is to replace the historic Hertel Exophthalmometer with a state-of-the-art mobile smartphone app that every ophthalmologist can carry in his pocket.

METHODS: The investigators developed an accurate and easy to use method for measuring abnormal eyeball protrusion using the TrueDepth camera of the iPhone 11 in comparison with a high-resolution 3D scanner as a reference to compare with the Hertel Exophthalmometer.

OUTCOMES:
  1. Accuracy and precision of 3D face-scanner and iPhone in comparison to Hertel Exophthalmometer.

  2. Test re-test reliability in comparison to Hertel Exophthalmometer.

  3. Inter-operator reliability against Hertel Exophthalmometer.

  4. Patients before and after exophthalmos changing treatment.

  5. Applicability in daily clinical practice.

BROADER IMPACT: The invention makes exophthalmometry quick, easy and objective. A mobile smartphone application would replace measurements with the traditional Hertel Exophthalmometer, which are cumbersome, prone to reading errors and have a poor inter-rater reliability as well as test-retest reliability.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
180 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Accuracy and precision of smartphone in comparison with 3D face scanner and Hertel exophthalmometer Test-retest reliability Inter-operator reliability Before and after exophthalmos-changing interventionAccuracy and precision of smartphone in comparison with 3D face scanner and Hertel exophthalmometer Test-retest reliability Inter-operator reliability Before and after exophthalmos-changing intervention
Masking:
None (Open Label)
Masking Description:
Blinding of the operators of Hertel exophthalmometer for previous measurement results.
Primary Purpose:
Diagnostic
Official Title:
Exophthalmometry With 3D Face Scanners
Actual Study Start Date :
Aug 14, 2019
Anticipated Primary Completion Date :
Dec 31, 2021
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Validation of smartphone face scanner

Validation of smartphone face scanner in comparison to Hertel Exophthalmometer and high-definition face scanner.

Device: Exophthalmos measurement
Exophthalmos measurement with iPhone 11 vs Artec Space Spider 3D Scanner vs Hertel Exophthalmometer.

Outcome Measures

Primary Outcome Measures

  1. Accuracy of the smartphone face scanner [On average 2 weeks]

    Accuracy of iPhone exophthalmos measurements (measured in mm for each eye) compared to measure with 3D face scanner and Hertel Exophthalmometer

  2. Test-retest-reliability of the smartphone face scanner [On average 2 weeks]

    Repeated measures (measured in mm for each eye) of the same subjects with iPhone 11, Hertel Exophthalmometer and 3D face scanner

  3. Inter-operator reliability of the smartphone face scanner [On average 2 weeks]

    Measurement (measured in mm for each eye) of the same patients by 3 different operators

  4. Smartphone face scanner measures before and after treatment with the smartphone face scanner [On average 3 months]

    Measurements (measured in mm for each eye) with the smartphone face scanner before and after exophthalmos-changing treatment

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Written informed consent

  • Able to cooperate with the study investigations (hearing, comprehension)

  • Exophthalmos (Grave's disease, orbital tumors, orbital inflammation, orbital fractures, rare causes (congenital, e.g. microphthalmos)

  • health controls

Exclusion Criteria:
  • Unable to sign informed consent

  • Unable to cooperate with the examinations (hearing loss, neurological deficits)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ophthalmology Department, University Hospital Zurich Zurich Switzerland CH-8091

Sponsors and Collaborators

  • University of Zurich

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Konrad Peter Weber, Principal Investigator, University of Zurich
ClinicalTrials.gov Identifier:
NCT04704414
Other Study ID Numbers:
  • BASEC-Nr. 2019-00233
  • CIV-19-08-029404
  • 10000520
First Posted:
Jan 11, 2021
Last Update Posted:
Jan 12, 2021
Last Verified:
Jan 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Konrad Peter Weber, Principal Investigator, University of Zurich
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 12, 2021